BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31817843)

  • 1. Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins.
    Pellett S; Tepp WH; Johnson EA
    Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31817843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in cell based assays for botulinum neurotoxin detection.
    Pellett S
    Curr Top Microbiol Immunol; 2013; 364():257-85. PubMed ID: 23239357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.
    Pellett S; Tepp WH; Johnson EA; Sesardic D
    J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):1-6. PubMed ID: 28465161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells.
    Pellett S; Du ZW; Pier CL; Tepp WH; Zhang SC; Johnson EA
    Biochem Biophys Res Commun; 2011 Jan; 404(1):388-92. PubMed ID: 21130748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal and specific quantitative detection of botulinum neurotoxin genes.
    Hill BJ; Skerry JC; Smith TJ; Arnon SS; Douek DC
    BMC Microbiol; 2010 Oct; 10():267. PubMed ID: 20961439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
    Pellett S; Tepp WH; Scherf JM; Johnson EA
    PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of extracellular and intracellular potency of botulinum neurotoxins.
    Cai F; Adrion CB; Keller JE
    Infect Immun; 2006 Oct; 74(10):5617-24. PubMed ID: 16988237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
    Bigalke H; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
    Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
    Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of Botulinum Toxins: Challenges and Opportunities for the Future.
    Rasetti-Escargueil C; Lemichez E; Popoff MR
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays.
    Schenke M; Schjeide BM; Püschel GP; Seeger B
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.
    Moritz MS; Tepp WH; Inzalaco HN; Johnson EA; Pellett S
    Toxicon; 2019 Sep; 167():20-28. PubMed ID: 31181297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics.
    Behrensdorf-Nicol HA; Wild E; Bonifas U; Klimek J; Hanschmann KM; Krämer B; Kegel B
    Toxicol In Vitro; 2018 Dec; 53():80-88. PubMed ID: 30016653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.
    Whitemarsh RC; Tepp WH; Bradshaw M; Lin G; Pier CL; Scherf JM; Johnson EA; Pellett S
    Infect Immun; 2013 Oct; 81(10):3894-902. PubMed ID: 23918782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination.
    Pellett S; Tepp WH; Toth SI; Johnson EA
    J Pharmacol Toxicol Methods; 2010; 61(3):304-10. PubMed ID: 20100585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish Sensitivity to Botulinum Neurotoxins.
    Chatla K; Gaunt PS; Petrie-Hanson L; Ford L; Hanson LA
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27153088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test.
    Worbs S; Fiebig U; Zeleny R; Schimmel H; Rummel A; Luginbühl W; Dorner BG
    Toxins (Basel); 2015 Nov; 7(12):4935-66. PubMed ID: 26703724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies.
    Pellett S; Tepp WH; Clancy CM; Borodic GE; Johnson EA
    FEBS Lett; 2007 Oct; 581(25):4803-8. PubMed ID: 17889852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.
    Duchesne de Lamotte J; Perrier A; Martinat C; Nicoleau C
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Detection of Botulinum Neurotoxins-A Review.
    Hobbs RJ; Thomas CA; Halliwell J; Gwenin CD
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31319550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.